This compound is a modified adenosine nucleoside analog, characterized by a fluoromethyl group at the 5' position of the sugar moiety. It serves as a specialty chemical intermediate or research reagent in the development of antiviral agents. Such fluorinated nucleosides are investigated for their potential to inhibit viral polymerases and interfere with RNA or DNA synthesis in viruses, including RNA viruses like coronaviruses and others. Due to its specific stereochemistry ((2R,3R,4S,5S)), it mimics natural nucleosides to study incorporation into viral genomes, potentially leading to chain termination. It is not a commodity chemical but a niche building block for pharmaceutical synthesis and antiviral research.